Correlation of clinical aspects as well as genotype and phenotype in Wilson's disease on the basis of epidemiologic, clinical and cranial MRI findings;Klinische und genotyp-phänotyp-korrelation epidemiologischer, bildgebender und neurologischer befunde bei patienten mit morbus Wilson

Fortschritte der Neurologie Psychiatrie

Volumn 74, Issue 10, 2006, Pages 558-566

  Hermann, Wieland ^a,b   Gunther P ^a   Schneider, J P ^a   Villmann, T ^a   Kuhn H J ^a   Eichelkraut, S ^a  

^a Paracelsusklinik Zwickau ^*  (Germany)

^b Paracelsus Klinik Zwickau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; BRAIN; CATION TRANSPORT PROTEINS; COHORT STUDIES; FEMALE; GENOTYPE; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE;

EID: 33750543387     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-919084     Document Type: Article

References (57)

1. Maier-Dobersberger T. Morbus Wilson. Diagnosestellung mit konventionellen und molekularbiologischen Methoden. Dtsch med Wschr 1999; 124: 493-496
2. Cuthbert JA. Wilson's disease: A new gene and animal model for an old disease. J Investig Med 1995; 43 (4): 323-336
3. Cox DW. Molecular advances in Wilson Disease. Prog Liver Dis 1996; 14: 245-264
4. Marsden CD. Wilson's disease. Q J Med 1987; 65: 959-966
5. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpainter G, Strohmeyer G. Wilson's disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115: 720-726
6. Roberts EA, Cox DW. Wilson disease. Bailliere's Clinical Gastroenterology 1998; 12 (2): 237-256
7. Jaspert A, Claus D, Lang C, Kolominsky P, Neundörfer B. Klinik, neurologische Diagnostik und Therapie des M. Wilson. In: Huffmann G, Braune H-J, Henn K-H (Hrsg). Extrapyramidalmotorische Erkrankungen. Reinbek: Einhorn, 1994: 551-555
8. Schlaug G, Hefter H, Engelbrecht V, Kuwert T, Arnold S, Stöcklin G, Seitz RJ. Neurological impairment and recovery in Wilson's disease: evidence from PET and MRI. J Neurol Sci 1996; 136: 129-139
9. Roh JK, Lee TG, Wie BA, Lee SB, Park SH, Chang KH. Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease. Neurology 1994; 44: 1064-1068
10. Selwa LM, Vanderzant CW, Brunberg JA, Brewer GJ, Drury I, Beydoun A. Correlation of evoked potentials and MRI findings in Wilson's disease. Neurology 1993; 43: 2059-2064
11. Hall HC. La degenerescence hepato-lenticulaire. Maladie de Wilson-Pseudosklerose Masson. Paris, 1921: 361
12. Beam AG. A genetical analysis of thirty families with Wilson's disease (hepatolentical degeneration). Ann Hum Genet 1960; 24: 33-43
13. Frydman M, Bonne-Tamir B, Farrer LA, Conneally PM, Magazanik A, Ashbel S, Goldwitch Z. Assignment of the gene for Wilson's disease to chromosome 13: Linkage to the esterase D locus. Proc Nat Acad Sci USA 1985; 82: 1819-1821
14. Bowcock AM, Farrer LA, Hebert JM et al. Eight closely linked loci place the Wilson disease locus within 13q14-q21. Am J Hum Genet 1988; 43: 664-674
15. Bull PC, Thomas GR, Kommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-Type ATPase similar to the Menkes gene. Nature Genetics 1993; 5: 327-337
16. Petruhkin K, Fischer SG, Piratsu M et al. Mapping, cloning and genetic characterization of the region containing the Wilson's disease gene. Nature Genetics 1993; 5: 338-343
17. Tanzi RE, Petrukhin K, Chernov I et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genetics 1993; 5: 343-350
18. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993; 197: 271-277
19. Payne AS, Kelly EJ, Giltlin D. Functional expression of the Wilson's disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q. mutation. Proc Natl Acad Sci 1998; 95: 10854-10859
20. Shah AB, Chernov I, Zhang HT et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997; 61: 317-328
21. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28: 28-36
22. Cox DW, Thomas GR, Roberts EA, Walshe JM. The Wilson Disease gene: Clinical implications. Hepatology 1994; 20 (4 Pt 2): 267 (Abstract)
23. Bachmann H, Lössner J, Biesold D. Untersuchungen zur Wilsonschen Erkrankung in der DDR. Teil 1: Genetik und Epidemiologie. Z ges Inn Med 1979; 34: 744-748
24. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith Jr LH (Hrsg). Major Problems in Internal Medicine, Vol.23. Philadelphia: Saunders, 1984
25. DiDonato M, Bibudhendra S. Copper transport and its alteration in Menkes and Wilson diseases. Biochemica et Biophysica Acta 1997; 1360: 3-16
26. Kenney S, Cox DW. The Wilson Disease Database and its contents are Copyright (1999-2000 University of Alberta. Last updated march 7th 2000. http://www.medgen.med.ualberta.ca/database.html
27. Ferenci P. Wilson's disease. Ital J Gastroenterol Hepatol 1999; 31: 416-425
28. Czlonkowska A, Rodo M, Gajda J, Ploos van Amstel HK, Juyn J, Houwen RHJ. Verv high frequency of the Hisl069Gln mutation in Polish Wilson disease patients. J Neurol 1997; 244: 591-592
29. Maier-Dobersberger T, Ferenci P, Polli C et al. Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 1997; 127: 21-26
30. Caca K, Ferenci P, Kühn H-J et al. High prevalence of the H1069Q mutation in Easet German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 2001; 35: 575-581
31. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nature Genetics 1995; 9: 210-217
32. Houwen RH, Juyn J, Hoogenraad TU, Ploos van Amstel JK, Berger R. R714Q mutation in Wilson disease is associated with late neurological presentation. J Med Genet 1995; 32: 480-482
33. Stapelbroek JM, Bollen CW, Ploos van Amstel JK et al. The H1069Q mutation in is ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J Hepatol 2004; 41: 758-763
34. Forbes JR, Cox DW. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant? Am J Hum Genet 1998; 68: 1663-1674
35. Schiefermeier M, Kolleger H, Madl C, Polli C, Oder W, Kühn HJ, Berr F, Ferenci P. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain 2000; 123: 585-590
36. Schöls L, Rieß O. Kupferstoffwechselstörungen. In: Rieß O, Schöls L (Hrsg). Neurogenetik. Berlin: Springer, 1998: 218-222
37. Hefter H, Arendt G, Stremmel W, Freund HJ. Motor impairment in Wilson's disease, I: slowness of voluntary limb movements. Acta Neurol Scand 1993; 87: 133-147
38. Hermann W, Barthel H, Hesse S, Grahmann F, Kühn H-J, Wagner A, Villmann T. Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal-motoric brain regions. J Neurol 2002; 249: 896-901
39. Hermann W, Villmann T, Wagner A. Elektrophysiologisches Schädigungsprofil von Patienten mit einem Morbus Wilson. Der Nervenarzt 2003; 10: 881-887
40. Prayer L, Wimberger D, Kramer J, Grimm G, Oder W, Imhof H. Cranial MRI in Wilson's disease. Neuroradiology 1990; 32: 211-214
41. Thuomas KA, Aquilonius SM, Bergström K, Westermark K. Magnetic resonance imaging of the brain in Wilson's disease. Neuroradiology 1993; 35: 447-452
42. Cuthbert AJ. Wilson's Disease: A new gene and an animal model for an old disease. J Investig Med 1995; 43 (4): 323-336
43. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nature Genetics 1995; 9: 210-217
44. Czlonkowska A, Rodo M, Gajda J, Ploos van Amstel HK, Juyn J, Houwen RHJ. Verv high frequency of the Hisl069Gln mutation in Polish Wilson disease patients. J Neurol 1997; 244: 591-592
45. Portala K. Psychopathology in Wilson's Disease. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 2001: 1-61
46. Nijeholt JL, Korf J. Wilson's disease and monoamines. Arch Neurol 1978; 35: 617
47. Hawkins RA, Mazziotta JC, Phelps ME. Wilson's disease studied with FDG and positron emission tomography. Neurology 1987; 37: 1707-1711
48. Snow BJ, Bhatt M, Martin WRW, Li D, Calne DB. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991; 54: 12-17
49. 123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurosurg Psychiatry 1998; 65: 60-64
50. Oertel WH, Tatsch K, Schwarz J et al. Decrease of D2 receptors indicated by 123 I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease. Ann Neurol 1992; 32: 743-748
51. Westermark K, Tedroff J, Thoumas K-A et al. Neurological Wilson's Disease Studied with Magnetic Resonance Imaging and with Positron Emission Tomography Using Dopaminergic Markers. Movement Disorders 1995; 10: 596-603
52. Hermann W, Villmann T, de Groot M, Grahmann F, Wagner A. Kinesiologische Diagnostik bei Morbus Wilson. Klinische Neurophysiologie 2000; 2: 94-100
53. Hermann W, Wagner A, Kühn H-J, Grahmann F, Villmann T. Classification of fine motoric disturbances in Wilson's disease using artifical neural networks. Acta Neurol Scand 2005; 111: 400-406
54. Roach ES, Ford CS, Spudis EV et al. Wilson's disease: evoked potentials and computed tomography. J Neurol 1985; 232: 20-23
55. Huster D, Hoppert M, Lutsenko S et al. Defective cellular localisation of mutant ATP 7B in Wilson's disease patients and hepatoma cell lines. Gastroenterology 2003; 124: 335-345
56. Forbes JR, Cox D. Copper-dependent trafficking of Wilson's disease mutant ATP 7B proteins. Hum Mol Genet 2000; 9: 1927-1935
57. Ferenci P, Zollner G, Trauner M. Hepatic transport systems. J Gastroenterol Hepatol 2002; 17: 105-112